万孚生物呼吸道三联家庭自测版和专业版产品获美国FDA 510(k)许可

Core Viewpoint - Wanfu Biology has received FDA authorization for its respiratory triple detection products, which are timely given the high incidence of respiratory infectious diseases in the U.S. [1] Company Summary - Wanfu Biology's U.S. subsidiary has obtained FDA 510(k) clearance for two products: a home testing kit and a professional use testing kit for the detection of COVID-19, Influenza A, and Influenza B viruses [1] - The products are designed for both home self-testing and professional use, expanding the company's market reach in the diagnostics sector [1]